These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 30177044

  • 21. Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study.
    Tarca AL, Taran A, Romero R, Jung E, Paredes C, Bhatti G, Ghita C, Chaiworapongsa T, Than NG, Hsu CD.
    Am J Obstet Gynecol; 2022 Jan; 226(1):126.e1-126.e22. PubMed ID: 34998477
    [Abstract] [Full Text] [Related]

  • 22. Diagnostic Biomarkers in Women With Suspected Preeclampsia in a Prospective Multicenter Study.
    Duckworth S, Griffin M, Seed PT, North R, Myers J, Mackillop L, Simpson N, Waugh J, Anumba D, Kenny LC, Redman CWG, Shennan AH, Chappell LC.
    Obstet Gynecol; 2016 Aug; 128(2):245-252. PubMed ID: 27400001
    [Abstract] [Full Text] [Related]

  • 23. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia.
    Cim N, Kurdoglu M, Ege S, Yoruk I, Yaman G, Yildizhan R.
    J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1602-1607. PubMed ID: 27658884
    [Abstract] [Full Text] [Related]

  • 24. Soluble fms-Like Tyrosine Kinase-1-to-Placental Growth Factor Ratio and Time to Delivery in Women With Suspected Preeclampsia.
    Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennström M, Olovsson M, Brennecke SP, Stepan H, Allegranza D, Dinkel C, Schoedl M, Dilba P, Hund M, Verlohren S.
    Obstet Gynecol; 2016 Aug; 128(2):261-269. PubMed ID: 27399996
    [Abstract] [Full Text] [Related]

  • 25. Association of cord blood Ang-1 and sCD105 levels with bronchopulmonary dysplasia in preterm infants.
    Yang J, Wang Y, Wu Y, Fan H, Jin O, Tang L, Tung TH, Zhang M, Wang L.
    BMC Pediatr; 2024 Jul 15; 24(1):451. PubMed ID: 39010003
    [Abstract] [Full Text] [Related]

  • 26. A longitudinal analysis of angiotensin II type 1 receptor antibody and angiogenic markers in pregnancy.
    Aggarwal S, Sunderland N, Thornton C, Xu B, Hennessy A, Makris A.
    Am J Obstet Gynecol; 2017 Feb 15; 216(2):170.e1-170.e8. PubMed ID: 27793555
    [Abstract] [Full Text] [Related]

  • 27. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
    Kim MY, Buyon JP, Guerra MM, Rana S, Zhang D, Laskin CA, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Porter TF, Merrill JT, Stephenson MD, Gao Q, Karumanchi SA, Salmon JE.
    Am J Obstet Gynecol; 2016 Jan 15; 214(1):108.e1-108.e14. PubMed ID: 26432463
    [Abstract] [Full Text] [Related]

  • 28. Maternal and Perinatal Outcomes Associated With Extremely High Values for the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio.
    Villalaín C, Herraiz I, Valle L, Mendoza M, Delgado JL, Vázquez-Fernández M, Martínez-Uriarte J, Melchor Í, Caamiña S, Fernández-Oliva A, Villar OP, Galindo A.
    J Am Heart Assoc; 2020 Apr 07; 9(7):e015548. PubMed ID: 32248765
    [Abstract] [Full Text] [Related]

  • 29. Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort.
    Andersen LB, Dechend R, Jørgensen JS, Luef BM, Nielsen J, Barington T, Christesen HT.
    Hypertens Pregnancy; 2016 Aug 07; 35(3):405-19. PubMed ID: 27159383
    [Abstract] [Full Text] [Related]

  • 30. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
    Leaños-Miranda A, Campos-Galicia I, Isordia-Salas I, Rivera-Leaños R, Romero-Arauz JF, Ayala-Méndez JA, Ulloa-Aguirre A.
    J Hypertens; 2012 Nov 07; 30(11):2173-81. PubMed ID: 22902831
    [Abstract] [Full Text] [Related]

  • 31. Preeclampsia and risk of developing bronchopulmonary dysplasia in very preterm neonates.
    Wilmink FA, Reijnierse J, Reiss IKM, Steegers EAP, de Jonge RCJ, Research Consortium Neonatology South-West of the Netherlands.
    Pregnancy Hypertens; 2019 Jan 07; 15():57-63. PubMed ID: 30825928
    [Abstract] [Full Text] [Related]

  • 32. Circulating angiogenic factors and HIV among pregnant women in Zambia: a nested case-control study.
    Smithmyer ME, Mabula-Bwalya CM, Mwape H, Chipili G, Spelke BM, Kasaro MP, De Paris K, Vwalika B, Sebastião YV, Stringer JSA, Price JT.
    BMC Pregnancy Childbirth; 2021 Jul 28; 21(1):534. PubMed ID: 34320947
    [Abstract] [Full Text] [Related]

  • 33. Increased incidence of bronchopulmonary dysplasia in preterm infants exposed to preeclampsia.
    Ozkan H, Cetinkaya M, Koksal N.
    J Matern Fetal Neonatal Med; 2012 Dec 28; 25(12):2681-5. PubMed ID: 22759075
    [Abstract] [Full Text] [Related]

  • 34. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
    Aggarwal PK, Chandel N, Jain V, Jha V.
    J Hum Hypertens; 2012 Apr 28; 26(4):236-41. PubMed ID: 21451568
    [Abstract] [Full Text] [Related]

  • 35. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
    Gao J, Shen J, Jiang Y, Zhou X, Qi H, Liu X, Liu J, Yang J, Bian X.
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jan 28; 49(1):22-5. PubMed ID: 24694913
    [Abstract] [Full Text] [Related]

  • 36. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM, Roland MC, Henriksen T, Michelsen TM.
    Am J Obstet Gynecol; 2016 Dec 28; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [Abstract] [Full Text] [Related]

  • 37. Levels of serum-circulating angiogenic factors within 1 week prior to delivery are closely related to conditions of pregnant women with pre-eclampsia, gestational hypertension, and/or fetal growth restriction.
    Nanjo S, Minami S, Mizoguchi M, Yamamoto M, Yahata T, Toujima S, Shiro M, Kobayashi A, Muragaki Y, Ino K.
    J Obstet Gynaecol Res; 2017 Dec 28; 43(12):1805-1814. PubMed ID: 28929598
    [Abstract] [Full Text] [Related]

  • 38. Peripheral arterial tonometry and angiogenic biomarkers in preeclampsia.
    Kumer K, Premru-Sršen T, Fabjan-Vodušek V, Tul N, Fabjan T, Osredkar J.
    Hypertens Pregnancy; 2018 Nov 28; 37(4):197-203. PubMed ID: 30282501
    [Abstract] [Full Text] [Related]

  • 39. Circulating Angiogenic Factors and the Risk of Preeclampsia in Systemic Lupus Erythematosus Pregnancies.
    Leaños-Miranda A, Campos-Galicia I, Berumen-Lechuga MG, Molina-Pérez CJ, García-Paleta Y, Isordia-Salas I, Ramírez-Valenzuela KL.
    J Rheumatol; 2015 Jul 28; 42(7):1141-9. PubMed ID: 25979720
    [Abstract] [Full Text] [Related]

  • 40. Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women.
    Forest JC, Thériault S, Massé J, Bujold E, Giguère Y.
    Clin Chem Lab Med; 2014 Aug 28; 52(8):1169-78. PubMed ID: 24535301
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.